Description
Title: AirFluSal®: Another treatment for astma or a significant advance in the management of therapeutic recommendations?
Abstract: It is difficult to effectively treat astma and peptic ulcer disease (POChP). Despite the fact that there are numerous anti-statism medications, obtaining control of the disease causes us a great deal of problems. One of the main causes of his non-powdering is a lack of adherence to recommended treatment regimens for obturatory disease. Historycznie, according to the results of the study, the preparations containing the salmeterol/flutikazon combination were one of the medications whose use resulted in the best-performed zalecing. Currently, a powerful combination was introduced in the Forspiro® inhalator for the treatment of POChP. Recent research summarized the current state of affairs and mentioned new clinical trials involving AirFluSal Forspiro®. It appears that this lek may significantly improve the way that patients are treated for obturatory disorders.
Keywords: AirFluSal®, astma, POChP, zalecenia
Paper Quality: SCOPUS / Web of Science Level Research Paper
Subject: Advances in Respiratory Medicine
Writer Experience: 20+ Years
Plagiarism Report: Turnitin Plagiarism Report will be less than 10%
Restriction: Only one author may purchase a single paper. The paper will then indicate that it is out of stock.
What will I get after the purchase?
A turnitin plagiarism report of less than 10% in a pdf file and a full research paper in a word document.
In case you have any questions related to this research paper, please feel free to call/ WhatsApp on +919726999915
Reviews
There are no reviews yet.